Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina

Coronary Artery Disease

Volumn 22, Issue 7, 2011, Pages 451-457

  Mito, Takahiro ^a   Miura, Shin Ichiro ^a   Iwata, Atsushi ^a   Morii, Joji ^a   Sugihara, Makoto ^a   Ike, Amane ^a   Mori, Ken ^a   Kawamura, Akira ^a   Nishikawa, Hiroaki ^a   Zhang, Bo ^a   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

adiponectin; metabolic syndrome; percutaneous coronary intervention; restenosis

Indexed keywords

ADIPONECTIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HUMAN; HYPERADIPONECTINEMIA; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; RECEIVER OPERATING CHARACTERISTIC; RESTENOSIS; RISK FACTOR; STABLE ANGINA PECTORIS; TREATMENT OUTCOME;

ADIPONECTIN; AGED; ANGINA, STABLE; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 80053654722     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283495d43     Document Type: Article

References (28)

1. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257:79-83. (Pubitemid 29299050)
2. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G. Young men with highnormal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002; 25:971-976. (Pubitemid 41110480)
3. Furuhashi M, Ura N, Higashiura K, Miyazaki Y, Murakami H, Hyakukoku M, Shimamoto K. Low adiponectin level in young normotensive men with a family history of essential hypertension. Hypertens Res 2005; 28: 141-146. (Pubitemid 40663065)
4. Lee HS, Lee M, Joung H. Adiponectin represents an independent risk factor for hypertension in middle aged Korean women. Asia Pac J Clin Nutr 2007; 16:10-15. (Pubitemid 46280352)
5. Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH, et al. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 2007; 49:1455-1461. (Pubitemid 46809394)
6. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8:731-737. (Pubitemid 34778727)
7. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361:226-228. (Pubitemid 36126226)
8. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponection. Circulation 1999; 100:2473-2476. (Pubitemid 30005109)
9. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23:85-89. (Pubitemid 36091630)
10. Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004; 90:528-533. (Pubitemid 38530170)
11. Hoffman R, Mintz GS, Mehran R, Pichard AD, Kent KM, Satler LF, et al. Intravascular ultrasound predictors of angiographic restenosis in lesions treated with palmaz-schatz stents. J Am Coll Cardiol 1998; 31:43-49. (Pubitemid 28064720)
12. Gronenschild E, Janssen J, Tijdens F. CAAS.II: a second generation system for off-line and on-line quantitative coronary angiography. Cathet Cardiovasc Diagn 1994; 33:61-75. (Pubitemid 24303004)
13. Kojima S, Funahashi T, Maruyoshi H, Honda O, Sugiyama S, Kawano H, et al. Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma. Thromb Res 2005; 115:483-490. (Pubitemid 40409981)
14. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristics (ROC) curve. Radiology 1982; 143: 29-36. (Pubitemid 12142173)
15. Swets JA. ROC analysis applied to the evaluation of medical imaging techniques. Invest Radiol 1979; 14:109-121. (Pubitemid 9182004)
16. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978; 8:283-298. (Pubitemid 9075026)
17. Greiner M, Sohr D, Gobel P. A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J Immunol Methods 1995; 185:123-132.
18. Greiner M. Two-graph receiver operating characteristic (TG-ROC): update version supports optimization of cut-off values that minimize overall misclassification costs. J Immunol Methods 1996; 191:93-94. (Pubitemid 26163418)
19. Iwata A, Miura S, Mori K, Kawamura A, Nishikawa H, Saku K. Associations between metabolic factors and coronary plaque growth or arterial remodeling as assessed by intravascular ultrasound in patients with stable angina. Hypertens Res 2008; 31:1879-1886.
20. Moussa I, Di Mario C, Moses J. The impact of preintervention plaque area as determined by intravascular ultrasound on luminal renarrowing following coronary stenting. Circulation 1996; 94:I-261Abstract
21. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105:2893-2898. (Pubitemid 34666104)
22. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103:1057-1063. (Pubitemid 32200177)
23. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 109:2767-2770. (Pubitemid 35396973)
24. Matsuda M, Shimomura I, Sata M, Shimomura I, Sata M, Arita Y, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277:37487-37491.
25. Robert W, Peter B, Ryan J, Emmanouil S, Diane E, Virend K. Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J 2007; 28:292-298.
26. Fujimoto M, Masuzaki H, Tanaka T, Yasue S, Tomita T, Okazawa K, et al. An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes. FEBS Lett 2004; 576:492-497. (Pubitemid 39388651)
27. Furuya R, Odamaki M, Kumagai H, Hishida A. Impact of angiotensin II reseptor blocker on plasma levels of adiponectin and advanced oxidation protein products in peritoneal dialysis patients. Blood Purif 2006; 24:445-450. (Pubitemid 46030086)
28. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Shulthess T, et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: implications for metabolic regulation and bioactivity. J Biol Chem 2003; 278:9073-9085. (Pubitemid 36800387)